PARIS (Reuters) – Healthcare company Sanofi Aventis France said it had been placed under formal investigation on charges of manslaughter over Depakine, which is an epilepsy drug that caused birth malfunctions and slow neurological development when taken during... More »
PARIS (Reuters) – Healthcare companies Sanofi and Regeneron announced on Friday more encouraging results for their Dupixent product used to treat severe atopic dermatitis, often commonly known as eczema. The companies said that Dupixent Phase 3 data showed a s... More »
PARIS (Reuters) – Sanofi SA will be able to provide millions of doses of hydroxychloroquine for patients with the illness caused by the novel coronavirus if the old malaria drug proves successful in clinical trials, its chief executive told Reuters on Thursday... More »
(Reuters) – Drugs used for treating arthritis are being tested as treatments for COVID-19, the disease caused by a new coronavirus, as researchers rush to find ways of helping patients and slowing the number of infections. Sanofi and Regeneron Pharmaceuticals ... More »
PARIS (Reuters) – Sanofi (SASY.PA) said on Monday it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion aimed at beefing up the French drugmaker’s pipeline of drugs for cancer and auto-immune disorder... More »
NEW YORK (Reuters) – Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity. The French drugmaker said it was working with health autho... More »
(Reuters) – Lexicon Pharmaceuticals Inc said on Tuesday France’s Sanofi SA will pay the drugmaker $260 million for the termination of their partnership to develop diabetes drug Zynquista. Shares of Lexicon jumped 37.8% to $2.37 in after hours trading. Under th... More »
(Reuters) – French drugmaker Sanofi SA said on Friday it had terminated its partnership with Lexicon Pharmaceuticals Inc to develop and manufacture a drug for use with insulin in patients with type 1 and type 2 diabetes. Lexicon shares fell nearly 40% in exten... More »
(Reuters) – The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals Inc intended for use with insulin in patients with type 1 diabetes, the companies said on Friday. The decision comes about two month... More »
PARIS (Reuters) – The U.S. Food and Drug Administration approved Sanofi’s new pediatric vaccine immunizing children against six diseases, the French pharmaceutical lab said on Wednesday. Sanofi developed the new vaccine, dubbed Vaxelis, in partnership with Mer... More »
FILE PHOTO: French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo (Reuters) – A potent, expensive cholesterol drug sold by Regeneron Pharmaceuticals and Sanofi s... More »
(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA said on Saturday they would be willing to charge less for their potent cholesterol drug, Praluent, if insurers agree to lessen onerous access barriers for high-risk patients. Since the approvals in 2015 o... More »
Dr. Rolando Enrique Domingo (R), Undersecretary of the Department of Health (DOH), with Dr. Gerardo Legaspi, Director of the Philippine General Hospital (PGH), answer questions during a news conference at the DOH headquarter in metro Manila, Philippines Februa... More »
FILE PHOTO: A health worker shows unused packs of anti-dengue vaccine Dengvaxia before returning it inside a freezer for storage at the Manila Health Department in Sta Cruz, metro Manila, Philippines December 5, 2017. REUTERS/Romeo Ranoco/File Photo CHICAGO (R... More »
French multinational pharmaceutical company SANOFI logo seen at their headquater in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer – D1AESRMWVNAA PARIS (Reuters) – French healthcare group Sanofi has agreed to buy U.S. haemophilia specialist Bioverativ ... More »
PARIS (Reuters) – Shares in French drugmaker Sanofi fell on Monday after the company announced a $11.6 billion takeover of U.S. haemophilia treatment specialist Bioverativ, with some traders saying the price looked expensive. Sanofi shares were down 2.3 percen... More »
Concepcion Yusop, a national immunization program manager, shows an anti-dengue vaccine Dengvaxia inside a vaccine storage room in Sta. Cruz city, Metro Manila, Philippines December 4, 2017. REUTERS/Romeo Ranoco/File Photo MANILA (Reuters) – The Philippines wi... More »
FILE PHOTO: A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo MANILA (Reuters) – The Philippines ordered a probe on Monday into the immunisation of more than 730... More »
Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study. More »
French pharmaceutical group Sanofi (SASY.PA) is set to start the process to sell its generic drug business in Europe, and at least six funds have expressed interest to investment banks mandated by group, France's Le Figaro newspaper reported. More »
Sanofi and Regeneron's biotech drug dupilumab scored a hit in treating severe asthma, clinical trial data showed on Monday, raising competition in an expected multibillion-dollar market. More »
France’s Sanofi and partner Regeneron Pharmaceuticals said on Sunday their anti-cholesterol drug Praluent recorded positive results in its first dedicated studies involving patients with diabetes and high cholesterol. More »
FILE PHOTO – The logo of French drugmaker Sanofi is seen in front of the company’s headquarters in Paris, France, October 30, 2014. REUTERS/Christian Hartmann/File Photo Drugmakers Sanofi and Regeneron said on Saturday results from a one-year test of their Dup... More »
FILE PHOTO – The logo of French drugmaker Sanofi is seen in front of the company’s headquarters in Paris, France, October 30, 2014. REUTERS/Christian Hartmann/File Photo French drugmaker Sanofi and Swiss manufacturer Lonza will invest 270 million euros ($285 m... More »
FILE PHOTO – The logo of French drugmaker Sanofi is seen in front of the company’s headquarters in Paris, France, October 30, 2014. REUTERS/Christian Hartmann/File Photo Drugmaker Ipsen (IPN.PA) has agreed to buy five consumer healthcare products from bigger F... More »
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo A U.S. appeals court on Wednesday stayed an order that would have blocked Regeneron Pharmaceuticals Inc and... More »
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo France’s Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that San... More »
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo French drugmaker Sanofi (SASY.PA) and its U.S. partner Regeneron Pharmaceuticals (REGN.O) could win U.S. ap... More »
A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo French drugmaker Sanofi and Google owner Alphabet’s life sciences firm Verily are to invest about $500 million ... More »
LONDON French drugmaker Sanofi has poached one of AstraZeneca’s top scientists to be its new research head in another high-profile departure for the British drugmaker. Sanofi said on Tuesday that Yong-Jun Liu had been appointed as head of research with effect ... More »
PARIS Sanofi boosted its presence in cancer research on Monday by signing two deals with biotech companies worth up to $1.2 billion, as the French drugmaker plays catch-up with rivals in the hot research field. Shares in French biotech group Innate Pharma, one... More »
LONDON/NEW YORK/FRANKFURT Investment bank Lazard is working with Sanofi’s management to prepare a sale or listing of its Merial animal health unit, aiming to land the leading advisory job for the deal, which could value the business at up 12 billion euros ($12... More »
PARIS French drugmaker Sanofi said the European Commission had cleared its key cholesterol drug Praluent for the treatment of so-called “bad cholesterol,” or low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia. The dr... More »
PARIS Sanofi said on Monday a second late-stage Phase III study of its LixiLan diabetes drug had met its main target, readying it for regulatory submissions by the fourth quarter in the United States and the first quarter of next year in the European Union. Li... More »
